Sentence examples for patent concerns from inspiring English sources

Genovations' test results, for example, do not mention the Alzheimer's connection when reporting the presence of the ApoE gene -- mainly because of patent concerns on the use of this gene for all Alzheimer's applications.

Red Bend claims Google has known about its patent concerns since early September.

As many of the past decade's blockbuster drugs, including Pfizer's $12 billion Lipitor, continue to come off patent, concerns are growing as to whether and how the biopharma industry will replace revenues lost to generics (Kirchhoff and Schiereck, 2011).

Walker Digital argues that this gaming patent concerns a product and method of distributed electronic tournaments for a plurality of players that exchanges information with a central controller to influence game play while a player plays in the tournament, and stores player information to influence game play in a subsequent tournament.

Within three months following the filing of a request for reexamination under the provisions of section 302, the Director will determine whether a substantial new question of patentability affecting any claim of the patent concerned is raised by the request, with or without consideration of other patents or printed publications.

Like the Kinect, the console will use motion detection technology and T3 recently revealed that Microsoft had filed a patent concerning projecting augmented reality 3D images on walls, which would require you to wear Wi-Fi-enabled 3D glasses.

The patent concerned stents, surgical devices used to hold formerly clogged blood vessels open after heart surgery, and the jury said it based the damages on royalties and profits forgone by Cordis because Boston Scientific sold a competing stent.

Flowtab filed a patent concerning the "ability for merchant sellers and servers in hospitality establishments to use point-of-sale applications to send one-click/one-touch order-status notifications to mobile devices of their customers".

Professor Giacomo Frati holds a patent concerning stem cells in cardiovascular medicine (WO2005012510) and a patent concerning platelet lysate in regenerative medicine (WO/2013/042095).

GL is co-author of one patent concerning improved inhibitor tolerance of S. cerevisiae.

RJT and JSM have an ownership stake in a patent concerning tiRNAs and their diagnostic and therapeutic uses (International Patent No. AU2009/000423).